Skip to main content

PREDICIENDO GENOTIPOS EXITOSOS DE MYCOBACTERIUM TUBERCULOSIS COMBINANDO GENOMICA DE POBLACIONES, APROXIMACIONES FUNCIONALES Y MODELOS DE INFECCION

PID2019-104477RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections

  • Moreno-Molina, Miguel
  • Shubladze, Natalia
  • Khurtsilava, Iza
  • Avaliani, Zaza
  • Bablishvili, Nino
  • Torres-Puente, Manuela
  • Villamayor, Luis
  • Gabrielian, Andrei
  • Rosenthal, Alex
  • Vilaplana, Cristina
  • Gagneux, Sebastien
  • Kempker, Russell R
  • Vashakidze, Sergo
  • Comas, Iñaki
11 páginas, 5 figuras, 1 tabla, Polyclonal infections occur when at least two unrelated strains of the same pathogen are detected in an individual. This has been linked to worse clinical outcomes in tuberculosis, as undetected strains with different antibiotic resistance profiles can lead to treatment failure. Here, we examine the amount of polyclonal infections in sputum and surgical resections from patients with tuberculosis in the country of Georgia. For this purpose, we sequence and analyse the genomes of Mycobacterium tuberculosis isolated from the samples, acquired through an observational clinical study (NCT02715271). Access to the lung enhanced the detection of multiple strains (40% of surgery cases) as opposed to just using a sputum sample (0-5% in the general population). We show that polyclonal infections often involve genetically distant strains and can be associated with reversion of the patient's drug susceptibility profile over time. In addition, we find different patterns of genetic diversity within lesions and across patients, including mutational signatures known to be associated with oxidative damage; this suggests that reactive oxygen species may be acting as a selective pressure in the granuloma environment. Our results support the idea that the magnitude of polyclonal infections in high-burden tuberculosis settings is underestimated when only testing sputum samples., The authors were supported by projects SAF2016-77346-R and PID2019-104477RB-I00 awarded to IC and the grant BES-2017-079656 awarded to MM by the Spanish Ministry of Economy and Competitiveness and Ministry of Science, the ERC project 638553-TBACCELERATE awarded to IC, Spanish Government-FEDER Funds through CV contract CPII18/00031 and grant PI16/01511, and Generalitat Valencia Grant to I.C. (code PROMETEO/2020/012). The grant providers played no part in study design, data collection, and analysis, or the preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Gene evolutionary trajectories in Mycobacterium tuberculosis reveal temporal signs of selection

  • Chiner-Oms, Álvaro
  • López, Mariana G.
  • Moreno-Molina, Miguel
  • Furió, Victoria
  • Comas, Iñaki
11 páginas, 4 figuras, 1 tabla y fórmulas. Plots of all trajectories calculated (Dataset S7) have been deposited in Figshare (https://dx.doi.org/10.6084/m9.figshare.19335854). Previously published data were also used for this work [data from Brites et al. (4), Coll et al. (29), Stucki et al. (30), Guerra-Assunc¸~ao et al. (31), Zignol et al. (32), Bos et al. (33), Ates et al. (34), Comas et al. (10, 35), Borrell et al. (36), and Cancino-Mu~noz et al. (37)]., SignificancePrevious attempts to identify the action of natural selection in the Mycobacterium tuberculosis complex (MTBC) were limited by sample size and averaging across time and lineages. We investigate changes in selective pressures across time for every single gene of the MTBC. We developed a methodology to analyze temporal signals of selection in a large dataset (∼5,000 complete genomes) and showed that 1) almost half of the genes seem to have been under positive selection at some point in time; 2) experimentally confirmed epitopes tend to accumulate more mutations in deeper branches than in external branches; and 3) temporal signals identify genes that were conserved in the past but under positive selection in the present, suggesting ongoing adaptation to the host., This project received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program Grant 101001038 (TB-RECONNECT). In addition, this work was funded by Ministerio de Ciencia (Spanish Government) Project PID2019- 104477RB-I00 and Generalitat Valenciana Project AICO/2018/113. This research work was also funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

  • Antimycobacterial Susceptibility Testing Group
  • Georghiou, Sophia B.
  • Rodwell, Timothy C.
  • Korobitsyn, Alexei
  • Abbadi, Said H.
  • Ajbani, Kanchan
  • Alffenaar, Jan-Willem
  • Alland, David
  • Alvarez, Nataly
  • Andres, Sönke
  • Ardizzoni, Elisa
  • Aubry, Alexandra
  • Baldan, Rossella
  • Ballif, Marie
  • Barilar, Ivan
  • Böttger, Erik C.
  • Chakravorty, Soumitesh
  • Claxton, Pauline M.
  • Cirillo, Daniela M.
  • Comas, Iñaki
  • Coulter, Chris
  • Denkinger, Claudia M.
  • Derendinger, Brigitta
  • Desmond, Edward P.
  • Steenwinkel, Jurriaan E. M. de
  • Dheda, Keertan
  • Diacon, Andreas H.
  • Dolinger, David L.
  • Dooley, Kelly E.
  • Egger, Matthias
  • Ehsani, Soudeh
  • Farhat, Maha R.
  • Fattorini, Lanfranco
  • Finci, Iris
  • Fournier Le Ray, Laure
  • Furió, Victoria
  • Groenheit, Ramona
  • Gumbo, Tawanda
  • Heysell, Scott K.
  • Hillemann, Doris
  • Hoffmann, Harald
  • Hsueh, Po-Ren
  • Hu, Yi
  • Huang, Hairong
  • Hussain, Alamdar
  • Ismail, Farzana
  • Izumi, Kiyohiko
  • Jagielski, Tomasz
  • Johnson, John L.
  • Kambli, Priti
  • Kaniga, Koné
  • Karunaratne, G. H. R. Eranga
  • Sharma, Meenu Kaushal
  • Keller, Peter M.
  • Kelly, Ellis C.
  • Kholina, Margarita
  • Kohli, Mikashmi
  • Kranzer, Katharina
  • Laurenson, Ian F.
  • Limberis, Jason
  • Lin, S-Y. Grace
  • Liu, Yongge
  • López-Gavín, Alexandre
  • Lyander, Anna
  • Machado, Diana
  • Martínez Fernández, Elena
  • Masood, Faisal
  • Mitarai, Satoshi
  • Mvelase, Nomonde R.
  • Niemann, Stefan
  • Nikolayevskyy, Vladyslav
  • Maurer, Florian P.
  • Merker, Matthias
  • Miotto, Paolo
  • Omar, Shaheed V.
  • Otto-Knapp, Ralf
  • Palaci, Moisés
  • Palacios Gutiérrez, Juan José
  • Peacock, Sharon J.
  • Peloquin, Charles A.
  • Perera, Jennifer
  • Pierre-Audigier, Catherine
  • Pholwat, Suporn
  • Posey, James E.
  • Prammananan, Therdsak
  • Rigouts, Leen
  • Robledo, Jaime
  • Rockwood, Neesha
  • Rodrigues, Camilla
  • Salfinger, Max
  • Schechter, Marcos C.
  • Seifert, Marva
  • Sengstake, Sarah
  • Shinnick, Thomas
  • Shubladze, Natalia
  • Sintchenko, Vitali
  • Sirgel, Frederick
  • Somasundaram, Sulochana
  • Sterling, Timothy R.
  • Spitaleri, Andrea
  • Streicher, Elizabeth
  • Supply, Philip
  • Svensson, Erik
  • Tagliani, Elisa
  • Tahseen, Sabira
  • Takaki, Akiko
  • Theron, Grant
  • Torrea, Gabriela
  • Van Deun, Armand
  • van Ingen, Jakko
  • Van Rie, Annelies
  • van Soolingen, Dick
  • Vargas Jr, Roger
  • Venter, Amour
  • Veziris, Nicolas
  • Villellas, Cristina
  • Viveiros, Miguel
  • Warren, Robin
  • Wen, Shu'an
  • Werngren, Jim
  • Wilkinson, Robert J.
  • Yang, Caie
  • Yılmaz, F. Ferda
  • Zhang, Tingting
  • Zimenkov, Danila
  • Ismail, Nazir
  • Köser, Claudio U.
  • Schön, Thomas
11 páginas, 2 figuras, 1 tabla, Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance., I. Comas was supported by PID2019-104477RB-I00 from the Spanish Science Ministry and by ERC (CoG 101001038), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Fine-grain population structure and transmission patterns of Mycobacterium tuberculosis in southern Mozambique, a high TB/HIV burden area

  • Saavedra Cervera, Belén
  • López, Mariana G.
  • Chiner-Oms, Álvaro
  • García Marín, Ana María
  • Cancino-Muñoz, Irving
  • Torres-Puente, Manuela
  • Villamayor, Luis
  • Madrazo-Moya, Carlos Francisco
  • Mambuque, Edson
  • Sequera, Guillermo Víctor
  • Respeito, Durval
  • Blanco, Silvia
  • Augusto, Orvalho
  • López-Varela, Elisa
  • Garcia-Basteiro, Alberto L.
  • Comas, Iñaki
14 paginas, 5 figuras, 2 tablas., Genomic studies of the Mycobacterium tuberculosis complex (MTBC) might shed light on the dynamics of its transmission, especially in high-burden settings, where recent outbreaks are embedded in the complex natural history of the disease. To this end, we conducted a 1 year prospective surveillance-based study in Mozambique. We applied whole-genome sequencing (WGS) to 295 positive cultures. We fully characterized MTBC isolates by phylogenetics and dating evaluation, and carried out a molecular epidemiology analysis to investigate further associations with pre-defined transmission risk factors. The majority of strains (49.5%, 136/275) belonged to lineage (L) 4; 57.8 % of them (159/275) were in genomic transmission clusters (cut-off 5 SNPs), and a strikingly high proportion (45.5%) shared an identical genotype (0 SNP pairwise distance). We found two 'likely endemic' clades, comprising 67 strains, belonging to L1.2, which dated back to the late 19th century and were associated with recent spread among people living with human immunodeficiency virus (PLHIV). We describe for the first time the population structure of MTBC in our region, a high tuberculosis (TB)/HIV burden area. Clustering analysis revealed an unforeseen pattern of spread and high rates of progression to active TB, suggesting weaknesses in TB control activities. The long-term presence of local strains in Mozambique, which were responsible for large transmission among HIV/TB-coinfected patients, calls into question the role of HIV in TB transmission., This project received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programmes 101001038 (TB-RECONNECT), PID2019-104477RB-I00 from Ministerio de Economía y Competitividad (Spanish Government) (to I.C.). We acknowledge support from the Spanish Ministry of Science, Innovation and Universities through the ‘Centro de Excelencia Severo Ochoa 2019–2023’.Programme (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Programme. B.S receives a pre-doctoral fellowship from the Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia and co-funded by European Social Fund (AGAUR)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Epidemiological cluster identification using multiple data sources: an approach using logistic regression

  • Susvitasari, Kurnia
  • Tupper, Paul F.
  • Cancino-Muñoz, Irving
  • López, Mariana G.
  • Comas, Iñaki
  • Colijn, Caroline
In the management of infectious disease outbreaks, grouping cases into clusters and understanding their underlying epidemiology are fundamental tasks. In genomic epidemiology, clusters are typically identified either using pathogen sequences alone or with sequences in combination with epidemiological data such as location and time of collection. However, it may not be feasible to culture and sequence all pathogen isolates, so sequence data may not be available for all cases. This presents challenges for identifying clusters and understanding epidemiology, because these cases may be important for transmission. Demographic, clinical and location data are likely to be available for unsequenced cases, and comprise partial information about their clustering. Here, we use statistical modelling to assign unsequenced cases to clusters already identified by genomic methods, assuming that a more direct method of linking individuals, such as contact tracing, is not available. We build our model on pairwise similarity between cases to predict whether cases cluster together, in contrast to using individual case data to predict the cases' clusters. We then develop methods that allow us to determine whether a pair of unsequenced cases are likely to cluster together, to group them into their most probable clusters, to identify which are most likely to be members of a specific (known) cluster, and to estimate the true size of a known cluster given a set of unsequenced cases. We apply our method to tuberculosis data from Valencia, Spain. Among other applications, we find that clustering can be predicted successfully using spatial distance between cases and whether nationality is the same. We can identify the correct cluster for an unsequenced case, among 38 possible clusters, with an accuracy of approximately 35 %, higher than both direct multinomial regression (17 %) and random selection (< 5 %)., This project received funding from the Euroepan Research Council ERC TB-RECONNECT 101001038, Ministerio de Ciencia (Spanish Government) PID2019-104477RB-100 and by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Deciphering the Tangible Spatio-Temporal Spread of a 25-Year Tuberculosis Outbreak Boosted by Social Determinants

  • López, Mariana G.
  • Campos-Herrero, M. Isolina
  • Torres-Puente, Manuela
  • Canas, Fernando
  • Comin, Jessica
  • Copado, Rodolfo
  • Wintringer, Penelope
  • Iqbal, Zamin
  • Lagarejos, Eduardo
  • Moreno-Molina, Miguel
  • Pérez-Lago, Laura
  • Pino, Berta
  • Sante, Laura
  • García de Viedma, Darío
  • Samper, Sofia
  • Comas, Iñaki
15 páginas, 5 figuras, 1 tabla, Outbreak strains of Mycobacterium tuberculosis are promising candidates as targets in the search for intrinsic determinants of transmissibility, as they are responsible for many cases with sustained transmission; however, the use of low-resolution typing methods and restricted geographical investigations represent flaws in assessing the success of long-lived outbreak strains. We can now address the nature of outbreak strains by combining large genomic data sets and phylodynamic approaches. We retrospectively sequenced the whole genome of representative samples assigned to an outbreak circulating in the Canary Islands (the GC strain) since 1993, which accounts for ~20% of local tuberculosis cases. We selected a panel of specific single nucleotide polymorphism (SNP) markers for an in-silico search for additional outbreak-related sequences within publicly available tuberculosis genomic data. Using this information, we inferred the origin, spread, and epidemiological parameters of the GC strain. Our approach allowed us to accurately trace the historical and more recent dispersion of the GC strain. We provide evidence of a highly successful nature within the Canarian archipelago but limited expansion abroad. Estimation of epidemiological parameters from genomic data disagree with a distinctive biology of the GC strain. With the increasing availability of genomic data allowing for the accurate inference of strain spread and critical epidemiological parameters, we can now revisit the link between Mycobacterium tuberculosis genotypes and transmission, as is routinely carried out for SARS-CoV-2 variants of concern. We demonstrate that social determinants rather than intrinsically higher bacterial transmissibility better explain the success of the GC strain. Importantly, our approach can be used to trace and characterize strains of interest worldwide. IMPORTANCE Infectious disease outbreaks represent a significant problem for public health. Tracing outbreak expansion and understanding the main factors behind emergence and persistence remain critical to effective disease control. Our study allows researchers and public health authorities to use Whole-Genome Sequencing-based methods to trace outbreaks, and shows how available epidemiological information helps to evaluate the factors underpinning outbreak persistence. Taking advantage of all the freely available information placed in public repositories, researchers can accurately establish the expansion of an outbreak beyond original boundaries, and determine the potential risk of a strain to inform health authorities which, in turn, can define target strategies to mitigate expansion and persistence. Finally, we show the need to evaluate strain transmissibility in different geographic contexts to unequivocally associate spread to local or pathogenic factors, an important lesson taken from genomic surveillance of SARS-CoV-2., This project has been funded by the European Research Council (101001038-TBRECONNECT), the Ministerio de Economía, Industria y Competitividad (PID2019-104477RB-I00), and the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global) to I.C. This project has been funded by the Instituto de Salud Carlos III (FIS18/0336) and the Gobierno de Aragón/Fondo Social Europeo “Construyendo Europa desde Aragón” to SS, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Tracking SARS-CoV-2 introductions in Mozambique using pandemic-scale phylogenies: a retrospective observational study

  • Martínez-Martínez, Francisco José
  • Massinga, Arsenia J
  • Jesus, Áuria De
  • Ernesto, Rita M.
  • Cano-Jiménez, Pablo
  • Chiner-Oms, Álvaro
  • Gómez-Navarro, Inmaculada
  • Guillot-Fernández, Marina
  • Guinovart, Caterina
  • Sitoe, Antonio
  • Vubil, Delfino
  • Bila, Rubao
  • Gujamo, Rufino
  • Enosse, Sonia
  • Jiménez-Serrano, Santiago
  • Torres-Puente, Manuela
  • Comas, Iñaki
  • Mandomando, Inacio
  • López, Mariana G.
  • Mayor, Alfredo
9 hojas, 4 figuras, 1 tabla. Demographic data of the participants are available in the appendix (pp 40–42). Genome sequences are publicly available on GISAID. All scripts used for the analysis, and beta and delta subtree files are publicly available at https://gitlab.com/tbgenomicsunit/mozcovid. The study protocol (appendix pp 1–35) and clinical questionnaire (appendix pp 36–39) will be available with publication, Background: From the start of the SARS-CoV-2 outbreak, global sequencing efforts have generated an unprecedented amount of genomic data. Nonetheless, unequal sampling between high-income and low-income countries hinders the implementation of genomic surveillance systems at the global and local level. Filling the knowledge gaps of genomic information and understanding pandemic dynamics in low-income countries is essential for public health decision making and to prepare for future pandemics. In this context, we aimed to discover the timing and origin of SARS-CoV-2 variant introductions in Mozambique, taking advantage of pandemic-scale phylogenies. Methods: We did a retrospective, observational study in southern Mozambique. Patients from Manhiça presenting with respiratory symptoms were recruited, and those enrolled in clinical trials were excluded. Data were included from three sources: (1) a prospective hospital-based surveillance study (MozCOVID), recruiting patients living in Manhiça, attending the Manhiça district hospital, and fulfilling the criteria of suspected COVID-19 case according to WHO; (2) symptomatic and asymptomatic individuals with SARS-CoV-2 infection recruited by the National Surveillance system; and (3) sequences from SARS-CoV-2-infected Mozambican cases deposited on the Global Initiative on Sharing Avian Influenza Data database. Positive samples amenable for sequencing were analysed. We used Ultrafast Sample placement on Existing tRees to understand the dynamics of beta and delta waves, using available genomic data. This tool can reconstruct a phylogeny with millions of sequences by efficient sample placement in a tree. We reconstructed a phylogeny (~7·6 million sequences) adding new and publicly available beta and delta sequences. Findings: A total of 5793 patients were recruited between Nov 1, 2020, and Aug 31, 2021. During this time, 133 328 COVID-19 cases were reported in Mozambique. 280 good quality new SARS-CoV-2 sequences were obtained after the inclusion criteria were applied and an additional 652 beta (B.1.351) and delta (B.1.617.2) public sequences were included from Mozambique. We evaluated 373 beta and 559 delta sequences. We identified 187 beta introductions (including 295 sequences), divided in 42 transmission groups and 145 unique introductions, mostly from South Africa, between August, 2020 and July, 2021. For delta, we identified 220 introductions (including 494 sequences), with 49 transmission groups and 171 unique introductions, mostly from the UK, India, and South Africa, between April and November, 2021. Interpretation: The timing and origin of introductions suggests that movement restrictions effectively avoided introductions from non-African countries, but not from surrounding countries. Our results raise questions about the imbalance between the consequences of restrictions and health benefits. This new understanding of pandemic dynamics in Mozambique can be used to inform public health interventions to control the spread of new variants. Funding: European and Developing Countries Clinical Trials, European Research Council, Bill & Melinda Gates Foundation, and Agència de Gestió d'Ajuts Universitaris i de Recerca., This publication was produced by MozCovid which is part of the EDCTP2 programme supported by the EU (grant number RIA2020EF-3005-MozCOVID). The COVID-19 testing was supported by Emory Global Health Institute, University of Emory, through the CHAMPS Program funded by the Bill & Melinda Gates Foundation (under the grant OPP1126780 to Robert Breiman, subcontract SC00003286). This work was also supported by the European Research Council under the EU’s Horizon 2020 Research and Innovation Program grant (101001038; TB-RECONNECT), the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global), the Departament d’Universitats i Recerca de la Generalitat de Catalunya (AGAUR; 2021 SGR 01517), and the Ministerio de Ciencia e Innovación (Spanish Government) Project PID2019–104477RB-I00. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya (http://cerca.cat/en/suma/). We also acknowledge support from the Spanish Ministry of Science and Innovation and State Research Agency through the Centro de Excelencia Severo Ochoa 2019–2023 Program (CEX2018–000806-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Monitoring of first-line drug resistance mutations outside the scope of Xpert MTB/RIF Ultra is needed for successful control of DR-TB in Southern Mozambique

  • Mariner-Llicer, Carla
  • Saavedra Cervera, Belén
  • Mambuque, Edson
  • Gomes, Neide
  • Munguambe, Shilzia
  • Villamayor, Luis M.
  • Cancino-Muñoz, Irving
  • Torres-Puente, Manuela
  • Nguenha, Dinis
  • Respeito, Durval
  • Tembe, Gustavo
  • López, Mariana G.
  • Comas, Iñaki
  • García-Basteiro, Alberto L.
Multidrug-resistant(MDR) tuberculosis in Southern Africa is of great concern, exacerbated by the spread of a clone harboring a mutation missed by Xpert Ultra. In Southern Mozambique, the presence of such mutation and rising cases of non-MDR isoniazid resistance highlights the need to ensure accurate detection of antimicrobial-resistance in the country., This work was supported by STOP TB partnership (STBP/TBREACH/GSA/W5-30: CA-3-D000920001 to AGB), the TB Portals program of the National Institutes of Health, the European Research Council (TB RECONNECT: H2020-ERC-COG/0800 to I. C.,), Generalitat Valenciana (AICO/2018/113 to I. C.) and the Spanish Ministry of Science and Innovation (PID2019-104477RB-I00 to I. C.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

VIPERA: Viral Intra-Patient Evolution Reporting and Analysis

  • Álvarez-Herrera, Miguel
  • Sevilla, Jordi
  • Ruiz-Rodríguez, Paula
  • Vergara, Andrea
  • Vila, Jordi
  • Cano-Jiménez, Pablo
  • González-Candelas, Fernando
  • Comas, Iñaki
  • Coscollá, Mireia
15 páginas, 9 figuras, Viral mutations within patients nurture the adaptive potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during chronic infections, which are a potential source of variants of concern. However, there is no integrated framework for the evolutionary analysis of intra-patient SARS-CoV-2 serial samples. Herein, we describe Viral Intra-Patient Evolution Reporting and Analysis (VIPERA), a new software that integrates the evaluation of the intra-patient ancestry of SARS-CoV-2 sequences with the analysis of evolutionary trajectories of serial sequences from the same viral infection. We have validated it using positive and negative control datasets and have successfully applied it to a new case, which revealed population dynamics and evidence of adaptive evolution. VIPERA is available under a free software license at https://github.com/PathoGenOmics-Lab/VIPERA., This work is a part of project CNS2022-135116 funded by MCIN/AEI/10.13039/501100011033, by the European Union Next GenerationEU/PRTR, and grant PID2021-123443OB-I00 funded by MICIN/AEI/10.13039/501100011033 and ERDF A way of making Europe. M.A.H. and P.R.R. are supported by the PTI+ Salud Global European Commission – NextGenerationEU (Regulation EU 2020/2094). J.S. is supported by the CSIC’s JAE intro program. F.G.C. was funded by project PID2021-127010OB-I00 from the Spanish Ministry of Science and CIPROM2021-053 from the Generalitat Valenciana. I.C. is funded by the European Research Council (101001038-TB-RECONNECT) and the Spanish Ministry of Economy, Industry and Competitiveness (PID2019-104477RB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis

  • García Marín, Ana María
  • Cancino-Muñoz, Irving
  • Torres-Puente, Manuela
  • Villamayor, Luis M.
  • Borrás, Rafael
  • Borrás-Máñez, María
  • Bosque, Montserrat
  • Camarena, Juan J.
  • Colomer-Roig, Ester
  • Colomina, Javier
  • Escribano, Isabel
  • Esparcia-Rodríguez, Oscar
  • Gil-Brusola, Ana
  • Gimeno-Cardona, Concepción
  • Gimeno-Gascón, Adelina
  • Gomila-Sard, Bárbara
  • González-Granda, Damiana
  • Gonzalo-Jiménez, Nieves
  • Guna-Serrano, María del Remedio
  • López-Hontangas, José Luis
  • Martín-González, Coral
  • Moreno-Muñoz, Rosario
  • Navarro, David
  • Navarro, María
  • Orta, Nieves
  • Pérez, Elvira
  • Prat, Josep
  • Rodríguez, Juan Carlos
  • Ruiz-García, María Montserrat
  • Vanaclocha, Hermelinda
  • González-Candelas, Fernando
  • Furió, Victoria
  • Valencia Region Tuberculosis Working Group
  • Comas, Iñaki
9 páginas, 2 figuras, 1 tabla, Background: In June, 2021, WHO published the most complete catalogue to date of resistance-conferring mutations in Mycobacterium tuberculosis. Here, we aimed to assess the performance of genome-based antimicrobial resistance prediction using the catalogue and its potential for improving diagnostics in a real low-burden setting. Methods: In this retrospective population-based genomic study M tuberculosis isolates were collected from 25 clinical laboratories in the low-burden setting of the Valencia Region, Spain. Culture-positive tuberculosis cases reported by regional public health authorities between Jan 1, 2014, and Dec 31, 2016, were included. The drug resistance profiles of these isolates were predicted by the genomic identification, via whole-genome sequencing (WGS), of the high-confidence resistance-causing variants included in the catalogue and compared with the phenotype. We determined the minimum inhibitory concentration (MIC) of the isolates with discordant resistance profiles using the resazurin microtitre assay. Findings: WGS was performed on 785 M tuberculosis complex culture-positive isolates, and the WGS resistance prediction sensitivities were: 85·4% (95% CI 70·8–94·4) for isoniazid, 73·3% (44·9–92·2) for rifampicin, 50·0% (21·1–78·9) for ethambutol, and 57·1% (34·0–78·2) for pyrazinamide; all specificities were more than 99·6%. Sensitivity values were lower than previously reported, but the overall pan-susceptibility accuracy was 96·4%. Genotypic analysis revealed that four phenotypically susceptible isolates carried mutations (rpoB Leu430Pro and rpoB Ile491Phe for rifampicin and fabG1 Leu203Leu for isoniazid) known to give borderline resistance in standard phenotypic tests. Additionally, we identified three putative resistance-associated mutations (inhA Ser94Ala, katG Leu48Pro, and katG Gly273Arg for isoniazid) in samples with substantially higher MICs than those of susceptible isolates. Combining both genomic and phenotypic data, in accordance with the WHO diagnostic guidelines, we could detect two new multidrug-resistant cases. Additionally, we detected 11 (1·6%) of 706 isolates to be monoresistant to fluoroquinolone, which had been previously undetected. Interpretation: We showed that the WHO catalogue enables the detection of resistant cases missed in phenotypic testing in a low-burden region, thus allowing for better patient-tailored treatment. We also identified mutations not included in the catalogue, relevant at the local level. Evidence from this study, together with future updates of the catalogue, will probably lead in the future to the partial replacement of culture testing with WGS-based drug susceptibility testing in our setting. Funding: European Research Council and the Spanish Ministerio de Ciencia., This project received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program Grant 101001038 (TB-RECONNECT; awarded to IC), from Ministerio de Ciencia (Spanish Government) Project PID2019-104477RB-I00 (awarded to IC), and from Generalitat Valenciana Project AICO/2018/113 (awarded to IC). AMG-M is funded by a Formación deProfesorado Universitario grant programme (FPU19/04562) from Ministerio de Universidades (Spanish Government). IC is also supported by the European Commission–NextGenerationEU, through Centro Superior de Investigaciones Científicas Global Health Platform (PTI Salud Global). We thank all the members of the Valencia Region Tuberculosis Working Group., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections

  • Moreno-Molina, Miguel|||0000-0003-0305-4445
  • Shubladze, Natalia|||0000-0003-0580-9629
  • Khurtsilava, Iza
  • Avaliani, Zaza
  • Bablishvili, Nino
  • Torres-Puente, Manuela|||0000-0002-8352-180X
  • Villamayor, Luis
  • Gabrielian, Andrei
  • Rosenthal, Alex|||0000-0003-4190-9045
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
  • Gagneux, Sebastien|||0000-0001-7783-9048
  • Kempker, Russell R.
  • Vashakidze, Sergo
  • Comas, I.|||0000-0001-5504-9408
Polyclonal infections occur when at least two unrelated strains of the same pathogen are detected in an individual. This has been linked to worse clinical outcomes in tuberculosis, as undetected strains with different antibiotic resistance profiles can lead to treatment failure. Here, we examine the amount of polyclonal infections in sputum and surgical resections from patients with tuberculosis in the country of Georgia. For this purpose, we sequence and analyse the genomes of Mycobacterium tuberculosis isolated from the samples, acquired through an observational clinical study (NCT02715271). Access to the lung enhanced the detection of multiple strains (40% of surgery cases) as opposed to just using a sputum sample (0-5% in the general population). We show that polyclonal infections often involve genetically distant strains and can be associated with reversion of the patient's drug susceptibility profile over time. In addition, we find different patterns of genetic diversity within lesions and across patients, including mutational signatures known to be associated with oxidative damage; this suggests that reactive oxygen species may be acting as a selective pressure in the granuloma environment. Our results support the idea that the magnitude of polyclonal infections in high-burden tuberculosis settings is underestimated when only testing sputum samples. Polyclonal infections occur when at least two unrelated strains of the same pathogen are detected in an individual. Here, Moreno-Molina et al. analyse sputum and surgical resections from tuberculosis patients, showing that the magnitude of polyclonal infections can be underestimated when only testing sputum samples.